PAULA ELLER: Open Payments
NPI 1508434093 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,109 in 53 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $103 · 2025 $1,109
Food & beverage: $1,067Travel & lodging: $41
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $265 |
| ACADIA Pharmaceuticals Inc | 5 | $116 |
| SK Life Science, Inc. | 3 | $90 |
| Biogen, Inc. | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Curonix LLC | 2 | $61 |
| PFIZER INC. | 3 | $56 |
| ARGENX US, INC. | 2 | $47 |
| UCB, Inc. | 2 | $45 |
| Amneal Pharmaceuticals LLC | 2 | $44 |
Products named: QULIPTA, NUPLAZID, TYSABRI, REXULTI, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, OCTAGAM IMMUNE GLOBULIN (HUMAN), UBRELVY, VYVGART HYTRULO.
Industry payments across PA — which companies pay providers there.
